Peter Lanyon

8.2k total citations · 2 hit papers
87 papers, 3.4k citations indexed

About

Peter Lanyon is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Peter Lanyon has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Rheumatology, 24 papers in Pulmonary and Respiratory Medicine and 24 papers in Immunology. Recurrent topics in Peter Lanyon's work include Systemic Lupus Erythematosus Research (24 papers), Vasculitis and related conditions (23 papers) and Systemic Sclerosis and Related Diseases (16 papers). Peter Lanyon is often cited by papers focused on Systemic Lupus Erythematosus Research (24 papers), Vasculitis and related conditions (23 papers) and Systemic Sclerosis and Related Diseases (16 papers). Peter Lanyon collaborates with scholars based in United Kingdom, United States and Italy. Peter Lanyon's co-authors include Michael Doherty, Matthew J. Grainge, Weiya Zhang, Frances Rees, Graham Davenport, Rachel Jones, David Jayne, Fiona Pearce, Chetan Mukhtyar and Bhaskar Dasgupta and has published in prestigious journals such as The Lancet, Ophthalmology and Annals of the Rheumatic Diseases.

In The Last Decade

Peter Lanyon

77 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

2008 794 citations David Jayne, Peter Lanyon et al. Annals of the Rheumatic Diseases profile →
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies

2017 489 citations Frances Rees, Michael Doherty et al. Lara D. Veeken profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Lanyon United Kingdom	29	1.8k	1.2k	841	525	428	87	3.4k
Véronique Le Guern France	29	1.9k 1.1×	996 0.8×	622 0.7×	483 0.9×	481 1.1×	111	3.4k
D. Lê Thi Huong France	35	2.2k 1.2×	1.2k 1.0×	893 1.1×	327 0.6×	241 0.6×	82	4.2k
J.C. Piette France	35	2.2k 1.2×	648 0.5×	921 1.1×	498 0.9×	422 1.0×	145	4.4k
W. Joseph McCune United States	23	1.4k 0.8×	988 0.8×	796 0.9×	221 0.4×	244 0.6×	41	2.5k
Christian Dejaco Austria	40	2.8k 1.5×	2.6k 2.1×	1.1k 1.4×	533 1.0×	335 0.8×	209	5.4k
José A. Gómez‐Puerta Spain	31	2.3k 1.3×	504 0.4×	820 1.0×	357 0.7×	307 0.7×	154	3.3k
Xinping Tian China	27	1.6k 0.8×	699 0.6×	774 0.9×	294 0.6×	350 0.8×	214	2.8k
Hasan Yazıcı Türkiye	19	1.8k 1.0×	2.1k 1.7×	451 0.5×	336 0.6×	244 0.6×	57	3.4k
Afzal Chaudhry United Kingdom	35	767 0.4×	1.2k 1.0×	1.1k 1.3×	578 1.1×	148 0.3×	68	3.5k
Víctor M. Martínez‐Taboada Spain	19	1.3k 0.7×	1.4k 1.1×	402 0.5×	191 0.4×	352 0.8×	65	2.5k

Countries citing papers authored by Peter Lanyon

Since Specialization

Citations

This map shows the geographic impact of Peter Lanyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lanyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lanyon more than expected).

Fields of papers citing papers by Peter Lanyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lanyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lanyon. The network helps show where Peter Lanyon may publish in the future.

Co-authorship network of co-authors of Peter Lanyon

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lanyon. A scholar is included among the top collaborators of Peter Lanyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lanyon. Peter Lanyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bishton, Mark, Matthew Collin, Richard Hubbard, et al.. (2025). Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study. The Lancet Rheumatology. 8(2). e108–e115.

Dures, Emma, Celia Almeida, Sadia Janjua, et al.. (2025). Patients’ experiences of managing their rare rheumatic disease. Lara D. Veeken. 64(11). 5698–5706.

Mumford, Lisa, Rachel Hogg, Peter Lanyon, et al.. (2025). Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study. The Lancet. 405(10475). 314–328. 1 indexed citations

Dures, Emma, Celia Almeida, Andrew J. Hunt, et al.. (2023). OA42 Patient experiences of managing their rare rheumatic disease. Lara D. Veeken. 62(Supplement_2). 1 indexed citations

Yee, Chee‐Seng, Caroline Gordon, Mohammed Akil, et al.. (2022). The BILAG-2004 index is associated with development of new damage in SLE. Lara D. Veeken. 62(2). 668–675. 2 indexed citations

Bishton, Mark, Tim Card, Peter Lanyon, et al.. (2021). A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population‐based health data. British Journal of Haematology. 194(6). 1039–1044. 3 indexed citations

Rutter, Megan, et al.. (2021). A systematic review and meta-analysis of the incidence rate of Takayasu arteritis. Lara D. Veeken. 60(11). 4982–4990. 37 indexed citations

Rutter, Megan, Peter Lanyon, Matthew J. Grainge, et al.. (2021). COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project. Lara D. Veeken. 61(8). 3161–3171. 12 indexed citations

McElhone, Kathleen, Janice Abbott, M. A. Hurley, et al.. (2020). . CLOK (University of Central Lancashire). 6 indexed citations

10.

Lam, Ching, David S. Sanders, Peter Lanyon, et al.. (2019). Increased fasting small‐bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging. United European Gastroenterology Journal. 7(10). 1353–1360. 5 indexed citations

11.

Royle, Jeremy, Peter Lanyon, Matthew J. Grainge, Abhishek Abhishek, & Fiona Pearce. (2018). The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clinical Rheumatology. 37(8). 2103–2111. 58 indexed citations

12.

Luqmani, Raashid, Anthea Craven, J Sznajd, et al.. (2017). WS2_1 The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV). Lara D. Veeken. 56(suppl_3). iii20–iii22. 2 indexed citations

13.

Pearce, Fiona, Richard Hubbard, Matthew J. Grainge, et al.. (2017). Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case–control study. QJM. 111(1). 39–45. 11 indexed citations

14.

Rees, Frances, Michael Doherty, Matthew J. Grainge, Peter Lanyon, & Weiya Zhang. (2017). The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Lara D. Veeken. 56(11). 1945–1961. 489 indexed citations breakdown →

15.

Isenberg, David, Anisur Rahman, David Jayne, et al.. (2014). Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register. UCL Discovery (University College London). 1 indexed citations

16.

McElhone, Kathleen, Chris Sutton, Janice Abbott, et al.. (2014). Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?. Value in Health. 17(7). A538–A538. 1 indexed citations

17.

Rees, Frances, Michael Doherty, Matthew J. Grainge, et al.. (2014). The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012. Annals of the Rheumatic Diseases. 75(1). 136–141. 212 indexed citations

18.

Neame, R, Weiya Zhang, Chris Deighton, et al.. (2004). Distribution of radiographic osteoarthritis between the right and left hands, hips, and knees. Arthritis & Rheumatism. 50(5). 1487–1494. 51 indexed citations

19.

Lanyon, Peter, et al.. (2004). Influence of radiographic phenotype on risk of hip osteoarthritis within families. Annals of the Rheumatic Diseases. 63(3). 259–263. 15 indexed citations

20.

Lanyon, Peter, Kenneth Muir, Sally Doherty, & Michael Doherty. (2003). Age and sex differences in hip joint space among asymptomatic subjects without structural change: Implications for epidemiologic studies. Arthritis & Rheumatism. 48(4). 1041–1046. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact